Laboratory of Haematooncology

We elucidate the mechanisms that regulate the maintenance and fate of haematopoietic stem cells, with particular interest in granulocytic differentiation

+ haematology, + haematopoietic stem cells, + neutrophilic differentiation, + granulocytes, + emergency granulopoiesis, + inflammation

Meritxell Alberich Jordà

Group leader

Meritxell Alberich Jordà

Scientific Career – Milestones

since 2015: Research Group Leader, IMG, Prague
2005-2012: Postdoctoral Fellow, Harvard Medical School, Harvard University, Boston, USA
2004: PhD, Erasmus MC, University of Rotterdam, The Netherlands

Identification of C/EBPα regulators in granulocytic differentiation

We have identified upstream and downstream regulators of C/EBPα, a crucial transcription factor that regulates granulocyte differentiation and is affected in a large percentage of acute myeloid leukemia (AML) cases. Understanding the regulatory networks of C/EBPα is important for the development of new therapeutic strategies for the treatment of AML. [pubmed] [doi]

Dissecting the molecular mechanisms regulating emergency granulopoiesis

We have elucidated how haematopoietic stem and progenitor cells contribute to the overproduction of granulocytes during granulopoiesis activated under stress conditions (e.g. acute infection). We have also identified new molecules involved in these mechanisms. [pubmed] [doi]

Detrimental effects of chronic inflammation on haematopoietic stem cell (HSC) fitness

By several projects in our laboratory, we have contributed to the understanding of how chronic inflammation alters the properties of haematopoietic stem cells and how it is harmful to them.

Research Reports

2017 – 2019 / 2015 – 2016

Additional information about group